Theron Pharmaceuticals
Sunnyvale, US · Delaware corporation
Founders & leadership
MS
Meenakshi Sundaram VenkatramanExecutive
XZ
Xiaoming ZhangExecutive
JR
Jurg R. PfisterExecutive
Board
JW
James W. LarrickBoard director
AK
Allan Kramer, M.D.Board director
CQ
Cary Queen, Ph.D.Board director
Reported raises · per SEC filings
Form D private placements$409.1K disclosed across 1 round · 2015
▶$409.1KraisedAug 2015 · 5 investors · PharmaceuticalsRule 506(b)
▶$409.1KraisedAug 2015 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Meenakshi Sundaram VenkatramanExecutive Officer
- James W. LarrickDirector
- Xiaoming ZhangExecutive Officer, Director
- Allan Kramer, M.D.Director
- Jurg R. PfisterExecutive Officer, Director
- Cary Queen, Ph.D.Director
- Offering amount
- $750K
- Amount sold
- $409.1K
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Theron Pharmaceuticals raised?
- Theron Pharmaceuticals has disclosed $409.1K raised across 1 round.
- Where is Theron Pharmaceuticals headquartered?
- Theron Pharmaceuticals is headquartered in Sunnyvale, US.